Silver Book Fact

Since 1980, 83 percent of gains in life expectancy for cancer patients have been attributable to new treatments.

Sun, E, D Lakdawalla, C Ryes, D Goldman, T Phillipson, et al. The Determinants of Recent Gains in Cancer Survival: An analysis of the Surveillance, Epidemiology, and End Results (SEER) database. J Clin Oncolo. 2008; 27(15S). http://meeting.ascopubs.org/cgi/content/short/26/15_suppl/6616

Reference

Title
The Determinants of Recent Gains in Cancer Survival: An analysis of the Surveillance, Epidemiology, and End Results (SEER) database
Publication
J Clin Oncolo
Publication Date
2008
Authors
Sun, E, D Lakdawalla, C Ryes, D Goldman, T Phillipson, et al.
Volume & Issue
Volume 27, Issue 15S
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • The 5-year survival rate for cancer has gone up 40 percent in the last 40 years.  
  • Every additional dollar spent on overall breast cancer treatment has produced health gains valued at $4.80.  
  • According to the Pharmaceutical Research and Manufacturers of America, a cancer medicine in the pipeline would inhibit production of a protein that may interfere with the effectiveness of chemotherapy.  
  • Between August 2004 and July 2014, the FDA approved: Six new anticancer therapeutics Five new uses for previously approved anticancer therapeutics Two new uses for imaging agents One new use for a screening test  
  • FDA approved cancer advances